Transcranial Focused Ultrasound for Parkinson's Disease
Effects of Transcranial Focused Ultrasound Stimulation (tFUS) on Neurological and Cognitive Outcomes in Parkinson's Disease
- Age
- 22 – 80
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 60 (estimated)
- Sponsor
- Sanmai Technologies PBC dba Sanmai · Industry
This trial is looking for adults with Parkinson's disease to test a new treatment called transcranial focused ultrasound. Participants will receive the treatment and be monitored for safety and effectiveness.
You may be able to join if
- I am between 22 and 80 years old.
- I have been diagnosed with idiopathic Parkinson's disease.
- My MDS-UPDRS Part III score is 25 or higher while off medication.
- I have been on stable dopaminergic therapy for at least 30 days.
- I can speak and understand English.
- I have normal or corrected hearing and vision.
- I am able to give informed consent.
You may not be able to join if
- I have atypical or secondary Parkinsonism.
- I have had deep brain stimulation or intracranial surgery.
- My MoCA score is below 23.
- I have severe psychiatric illness.
- I have a history of seizures or brain issues.
- I have significant neurologic diseases.
- I cannot have an MRI or ultrasound.
- I am currently pregnant or breastfeeding.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your EligibilityThis is a pilot randomized, sham-controlled, double-blind, multi-center study evaluating the safety and preliminary effectiveness of the Gen0Bh Transcranial Focused Ultrasound System for the treatment of motor symptoms in individuals with idiopathic Parkinson's disease.
Loading trial locations…